Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Routbort

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
Molecular Cancer Therapeutics|April 27, 2018
Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted TherapyHui Chen, Rajyalakshmi Luthra, Mark J Routbort, et al.
Blood|August 24, 2006
High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei)Weina Chen, Georgios Z Rassidakis, Jiang Li, et al.
Journal of Neuropathology and Experimental Neurology|April 11, 2017
Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain TumorsLeomar Y Ballester, Gregory N Fuller, Suzanne Z Powell, et al.
Journal of Clinical Pathology|April 17, 2016
Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agentsLanshan Huang, Guillermo Garcia-Manero, Elias Jabbour, et al.
American Journal of Hematology|November 10, 2006
Primary adrenal natural killer/T-cell nasal type lymphoma: first case report in adultsMichael A Thompson, Mouhammed A Habra, Mark J Routbort, et al.
American Journal of Hematology|May 12, 2017
Characterization of TP53 mutations in clonal cytopenia of undetermined significanceWei Wang, Mark J Routbort, Chi Young Ok, et al.
The American Journal of Surgical Pathology|January 31, 2015
Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistryKausar J Jabbar, Rajalakshmi Luthra, Keyur P Patel, et al.
Journal of Pathology Informatics|October 30, 2010
Tolerance testing of passive radio frequency identification tags for solvent, temperature, and pressure conditions encountered in an anatomic pathology or biorepository settingAlina A Leung, Jerry J Lou, Sergey Mareninov, et al.
Cytometry. Part B, Clinical Cytometry|June 19, 2019
Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones)Zhining Chen, Chi Young Ok, Wei Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
How Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?Sanam Loghavi, Mark J Routbort, Keyur P Patel, et al.
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
Molecular Cancer Therapeutics|April 27, 2018
Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted TherapyHui Chen, Rajyalakshmi Luthra, Mark J Routbort, et al.
Blood|August 24, 2006
High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei)Weina Chen, Georgios Z Rassidakis, Jiang Li, et al.
Journal of Neuropathology and Experimental Neurology|April 11, 2017
Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain TumorsLeomar Y Ballester, Gregory N Fuller, Suzanne Z Powell, et al.
Journal of Clinical Pathology|April 17, 2016
Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agentsLanshan Huang, Guillermo Garcia-Manero, Elias Jabbour, et al.
American Journal of Hematology|November 10, 2006
Primary adrenal natural killer/T-cell nasal type lymphoma: first case report in adultsMichael A Thompson, Mouhammed A Habra, Mark J Routbort, et al.
American Journal of Hematology|May 12, 2017
Characterization of TP53 mutations in clonal cytopenia of undetermined significanceWei Wang, Mark J Routbort, Chi Young Ok, et al.
The American Journal of Surgical Pathology|January 31, 2015
Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistryKausar J Jabbar, Rajalakshmi Luthra, Keyur P Patel, et al.
Journal of Pathology Informatics|October 30, 2010
Tolerance testing of passive radio frequency identification tags for solvent, temperature, and pressure conditions encountered in an anatomic pathology or biorepository settingAlina A Leung, Jerry J Lou, Sergey Mareninov, et al.
Cytometry. Part B, Clinical Cytometry|June 19, 2019
Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones)Zhining Chen, Chi Young Ok, Wei Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
How Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?Sanam Loghavi, Mark J Routbort, Keyur P Patel, et al.
Pageof 20